Erratum To: Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study

Thrombosis and Haemostasis - Germany
doi 10.1055/s-0038-1675417
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

Safety of 4-Factor Prothrombin Complex Concentrate (4f-Pcc) for Emergent Reversal of Factor Xa Inhibitors

Journal of Intensive Care
Critical CareIntensive Care Medicine
2018English

Comparison of Outcomes in Patients With Intracranial Hemorrhage on Factor Xa Inhibitors Versus Vitamin K Antagonists Treated With 4-Factor Prothrombin Complex Concentrate

Baylor University Medical Center Proceedings
Medicine
2018English

Three- Versus Four-Factor Prothrombin Complex Concentrate for the Reversal of Warfarin-Induced Bleeding

International Journal of Critical Illness and Injury Science
Emergency MedicinePublic HealthCritical CareEnvironmentalIntensive Care MedicineOccupational Health
2018English

Four-Factor Prothrombin Complex Concentrate (Beriplex® P/N) Is Superior to Three-Factor Prothrombin Complex Concentrate for Reversal of Coumarin Anticoagulation

Critical Care
Critical CareIntensive Care Medicine
2015English

Prothrombin Complex Concentrate

Reactions Weekly
2016English

Prothrombin Complex Concentrate

Reactions Weekly
2017English

Prothrombin Complex Concentrate

Reactions Weekly
2017English

Prothrombin-Complex-Concentrate

Reactions Weekly
2017English

Cost Minimization Analysis of Activated Prothrombin Complex Concentrate (Apcc) Compared to Recombinant Factor Viia (Rfviia) for Hemophilia Patients With Inhibitors

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy